FREDUN PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Fredun Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.41₹ -24.20
As on Dec 24, 2025, 4:01 PM IST
Fredun Pharmaceuticals Price Performance
Today's LowToday's High
₹1,658.70₹1,728.40
₹1,692.00
52 Weeks' Low52 Weeks' High
₹635.00₹1,999.00
₹1,692.00
Open Price
₹1,716.00
Prev. Close
₹1,716.20
Volume
11,029
Over the last 5 years, the share price of Fredun Pharmaceuticals has gained 39.39% CAGR. Over the past year, the corresponding return has been 129.47%.
Fredun Pharmaceuticals’s current P/E of 27.64x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Fredun Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Fredun Pharmaceuticals | 1.41 | -7.74 | 33.92 | 104.69 | 129.47 | 15.38 | 39.39 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Fredun Pharmaceuticals has gained 129.47% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Fredun Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,684.12 | 1,697.23 |
| 10 | 1,675.62 | 1,705.19 |
| 20 | 1,777.39 | 1,729.56 |
| 50 | 1,709.21 | 1,667.2 |
| 100 | 1,451.96 | 1,488.49 |
| 200 | 1,101.91 | 1,252.81 |
Fredun Pharmaceuticals Share Holding Pattern
In the latest quarter, Fredun Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 1.61%, FII holding rose to 0.01%, and public shareholding moved down to 49.46% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fredun Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 18, 2025, 11:51 PM IST | Fredun Pharma - Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Al |
| Dec 18, 2025, 6:28 AM IST | Fredun Pharma - Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Al |
| Dec 18, 2025, 1:25 AM IST | Fredun Pharma - Intimation Of Outcome Of Analysts/Investors Meeting Under The SEBI (Listing Obligations And Disclosures Requi |
| Nov 29, 2025, 11:35 PM IST | Fredun Pharma - Corrigendum Through General Announcement Regarding Disclosure Of Ultimate Beneficial Owners (Ubos), Pre -Pref |
| Nov 29, 2025, 3:02 AM IST | Fredun Pharma - Appointment of Company Secretary and Compliance Officer |
About Fredun Pharmaceuticals
Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 453.82 Cr. and Equity Capital is Rs. 4.72 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressURMI ESTATE, 11th Floor, Mumbai Maharashtra 400013
- Contact
Management
- Dr.(Mrs.) Daulat N MedhoraChairman & Jt. M. D
- Mr. Fredun MedhoraManaging Director & CFO
- Mrs. Daisy D�souzaInd. Non-Executive Director
- Mr. Anshu AgarwalInd. Non-Executive Director
- Dr. Rohinton KangaInd. Non-Executive Director
- Dr. Aspi RaimalwalaInd. Non-Executive Director
- Mrs. Sonal DesaiInd. Non-Executive Director
FAQs on Fredun Pharmaceuticals Share Price
What is the share price of Fredun Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Fredun Pharmaceuticals is ₹1,692.00 as on Dec 24, 2025.
What kind of stock is Fredun Pharmaceuticals?
The Fredun Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Fredun Pharmaceuticals?
The market cap of Fredun Pharmaceuticals is ₹798.91 Cr as on Dec 24, 2025.
What are today's High and Low prices of Fredun Pharmaceuticals?
Today’s highest and lowest price of Fredun Pharmaceuticals are ₹1,728.40 and ₹1,658.70.
What are the 52 Week High and 52 Week Low of Fredun Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Fredun Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Fredun Pharmaceuticals is ₹1,999.00 and 52-week low of Fredun Pharmaceuticals is ₹635.00 as on Dec 24, 2025.
How has the Fredun Pharmaceuticals performed historically in terms of returns?
The Fredun Pharmaceuticals has shown returns of -1.41% over the past day, -7.74% for the past month, 33.92% over 3 months, 129.47% over 1 year, 15.38% across 3 years, and 39.39% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Fredun Pharmaceuticals?
P/E ratio of and PB ratio of Fredun Pharmaceuticals are 27.64 and 5.07 on Dec 24, 2025. While the company gives a dividend yield of 0.04 per annum.
✕
Market Pulse